Deepinder Goyal’s health technology startup Temple is preparing for its next fundraising round at a $500 million valuation, reflecting growing investor confidence even before the commercial launch of its first wearable device. The company has also launched an Employee Stock Ownership Plan (ESOP) liquidity programme at a $375 million valuation, allowing eligible employees to sell part of their vested stock options ahead of the new funding round.
Temple, which emerged from stealth earlier this year, is developing a premium wearable focused on monitoring brain blood flow and cognitive performance. The startup raised $54 million in its seed funding round in February 2026 at a $190 million post-money valuation, backed by founder Deepinder Goyal, Peak XV Partners, Steadview Capital, Dharana Capital, Info Edge Ventures, and several prominent entrepreneurs.
Temple Targets $500 Million Valuation
According to people familiar with the matter, Temple is receiving strong interest from external investors as it prepares its next capital raise.
Founder Deepinder Goyal reportedly told employees that:
- Investor interest is building around a $500 million valuation.
- The company wants employees to benefit from the increase in value before the next funding round closes.
- An ESOP liquidity programme has therefore been introduced for early team members.
Funding Snapshot
| Item | Details |
|---|---|
| Latest Target Valuation | $500 million |
| ESOP Liquidity Valuation | $375 million |
| Seed Round (Feb. 2026) | $54 million |
| Seed Round Valuation | $190 million |
| Founder | Deepinder Goyal |
ESOP Buyback Rewards Early Employees
Temple has rolled out a partial ESOP buyback programme that enables approximately 20 employees to sell up to 25% of their vested stock options.
The programme:
- Values Temple at $375 million.
- Nearly doubles the company’s valuation from its February fundraising.
- Gives early employees an opportunity to realize gains before a larger institutional funding round.
ESOP liquidity events are relatively uncommon for startups at such an early stage, making Temple’s programme notable within India’s startup ecosystem.
Premium Wearable Nears Launch
Temple is preparing to launch its first wearable device, which is expected to be priced between ₹75,000 and ₹80,000.
The wearable is designed for premium users and aims to measure brain blood flow and cognitive performance, targeting applications in:
- High-performance athletics.
- Health monitoring.
- Cognitive optimization.
- Performance tracking.
The premium pricing reflects Temple’s strategy of entering the market with a specialized, high-end product rather than competing directly with mainstream smartwatch manufacturers.
Product Overview
| Feature | Details |
|---|---|
| Product Category | Brain-monitoring wearable |
| Expected Price | ₹75,000–₹80,000 |
| Target Users | Premium consumers and performance-focused users |
| Focus | Brain blood flow and cognitive monitoring |
Strong Backing From Investors
Temple’s seed round attracted several well-known investors from India’s technology ecosystem.
Backers include:
- Peak XV Partners.
- Steadview Capital.
- Dharana Capital.
- Info Edge Ventures.
- Founder Deepinder Goyal.
- More than 80 individual investors and entrepreneurs.
The company’s rapid increase in valuation—from $190 million to a potential $500 million within months—highlights investor optimism surrounding advanced health technology and AI-enabled wearable devices.
What the Valuation Signals
Temple remains in the pre-commercialization stage, making its valuation particularly noteworthy.
Investors appear to be betting on:
- Growth in digital health technologies.
- Rising demand for premium wearable devices.
- Advances in neurotechnology.
- Deepinder Goyal’s track record of building successful technology businesses.
If Temple completes its next fundraising at the targeted valuation, it would rank among India’s most highly valued early-stage health technology startups.
Looking Ahead
Temple’s planned fundraising at a $500 million valuation underscores growing investor confidence in advanced wearable technology and digital health, despite the company not yet launching its first commercial product. By pairing an employee liquidity programme with preparations for its next funding round, Deepinder Goyal is rewarding early team members while positioning the startup for its next phase of growth.
Looking ahead, the success of Temple will depend on the commercial reception of its premium brain-monitoring wearable and its ability to demonstrate meaningful health and performance benefits. If the company successfully executes its product launch and secures additional funding, it could emerge as a significant player in the rapidly evolving market for AI-powered health wearables and neurotechnology.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
